A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus
Status:
Completed
Trial end date:
2018-05-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and dose response of SK-1405
for the treatment of subjects with uremic pruritus receiving hemodialysis, during 2 weeks of
treatment.